sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Brain Cancer Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00025896
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 159
Buy Now

Asia Pacific Brain Cancer Diagnostics Market Analysis, Trends, and Scope 2022 to 2028

Buy Now

Asia Pacific Brain Cancer Diagnostics Market Report Asia Pacific Brain Cancer Diagnostics Market Size and Share Asia Pacific Brain Cancer Diagnostics Market Scope and Analysis

Asia Pacific Brain Cancer Diagnostics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 178.6 Million
Market Size by 2028 US$ 551.4 Million
Global CAGR (2021 - 2028) 17.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Diagnostic Type
  • Imaging Test
  • Lumbar Puncture
  • Biopsy
  • Molecular Testing
By Cancer Type
  • Acoustic Neuroma
  • Astrocytoma
  • Craniopharyngiomas
  • Ganglioneuromas
  • Glioblastoma Multiforme
  • Meningiomas
  • Ependymomas
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Siemens Healthineers A
  • GE Healthcare
  • Biocept Inc
  • Koninklijke Philips N V
  • Canon Medical Systems
  • Hitachi Ltd
  • Neusoft Medical Systems
    		•